Relapsing Polychondritis

Explore clinical trials studying Relapsing Polychondritis. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Relapsing Polychondritis trial results

Recruiting

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

NCT02257866

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, +26 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis

NCT06941376

Conditions: Cardiovascular Diseases, Cartilage Diseases, Connective Tissue Diseases, +6 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Longitudinal Study for Relapsing Polychondritis

NCT04919538

Conditions: Cardiovascular Diseases, Cartilage Diseases, Connective Tissue Diseases, +6 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

NCT06873100

Conditions: Cartilage Diseases, Connective Tissue Diseases, Musculoskeletal Diseases, +3 more
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis

NCT04077736

Conditions: Cartilage Diseases, Connective Tissue Diseases, Musculoskeletal Diseases, +3 more
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab

NCT01041248

Conditions: Cartilage Diseases, Connective Tissue Diseases, Musculoskeletal Diseases, +3 more
Locations: Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada

View Trial Details

Completed

Study on the Safety of Abatacept in Relapsing Polychondritis

NCT01272856

Conditions: Cartilage Diseases, Connective Tissue Diseases, Musculoskeletal Diseases, +3 more
Locations: Virginia Mason Medical Center Seattle, Washington, United States

View Trial Details

Relapsing Polychondritis

Relapsing Polychondritis trial results

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis

Longitudinal Study for Relapsing Polychondritis

Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis

Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab

Study on the Safety of Abatacept in Relapsing Polychondritis

Related conditions